Meloxicam
Escolar, M.; Sádaba, B.; Honorato, J.
Revista de Medicina de la Universidad de Navarra 41(2): 51-55
1997
ISSN/ISBN: 0556-6177 PMID: 9333923 Document Number: 477420
Document emailed within 1 workday
Related Documents
Bavbek, S.; Erkekol, F.O.; Dursun, B.; Misirligil, Z. 2006: Meloxicam-associated anaphylactic reaction Journal of Investigational Allergology and Clinical Immunology 16(5): 317-320Ilknur, T.; Fetil, E.; Akarsu, S.; Arda, F.üs.; Sis, B.; Günes, A.T. 2006: Development of psoriasis after meloxicam European Journal of Dermatology: Ejd 16(4): 444-445
Hiran, S.; Mazumdar, D.; Sarma, P.S.A. 2003: Acute thrombocytopenic purpura due to meloxicam Journal of the Association of Physicians of India 51: 531-532
Staerkel, P.; Horsmans, Y. 1999: Meloxicam-induced liver toxicity Acta Gastro-Enterologica Belgica 62(2): 255-256
Mazurov, V.I.; Beliaeva, I.B.; Onushchenko, I.A. 2001: Experience with meloxicam treatment of ankylosing spondylarthritis Klinicheskaia Meditsina 79(5): 53-55
Del Val, A.; Llorente, M.J.; Tenías, J.M.; Lluch, A. 1998: Upper digestive hemorrhage caused by meloxicam Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 90(6): 461-462
Lemmel, E.M.; Bolten, W.; Burgos-Vargas, R.; Platt, P.; Nissilä, M.; Sahlberg, D.; Björneboe, O.; Baumgartner, H.; Valat, J.P.; Franchimont, P.; Bluhmki, E.; Hanft, G.; Distel, M. 1997: Efficacy and safety of meloxicam in patients with rheumatoid arthritis Journal of Rheumatology 24(2): 282-290
Karateev, A.E. 2014: Meloxicam: the golden mean of nonsteroidal anti-inflammatory drugs Terapevticheskii Arkhiv 86(5): 99-105
Zafar, F.; Khan, S.; Ali, H.; Shah, S.N.; Bushra, R.; Naqvi, G.R.; Maroof, K.; Khan, M.A.; Nisa, Z. 2018: Biowaiver studies of newly optimized meloxicam tablets Pakistan Journal of Pharmaceutical Sciences 31(4 Supplary): 1469-1474
Induri, M.; Mantripragada, B.R.; Yejella, R.P.; Kunda, P.R.; Nannapaneni, D.T.; Boddu, R. 2012: Dissolution studies and quantification of meloxicam in tablet dosage form by spectrophotometry Pakistan Journal of Pharmaceutical Sciences 25(1): 283-287
Dobbie, Z.; Muller, P.Y.; Heinimann, K.; Albrecht, C.; D'Orazio, D.; Bendik, I.; Müller, H.; Bauerfeind, P. 2002: Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam Anticancer Research 22(4): 2215-2220
Baiza-Duran, L.M.; Quintana-Hau, J.; Tornero-Montaño, R.; Ortiz, M.I.; Castañeda-Hernández, G.; Alanis-Villarreal, L.; Avalos-Urzua, G.; Bustos-Zermeño, R.; Domene-Hinojosa, J.L.; Gómez-Bastar, P.; Ibañez-Hernandez, M.A.; Morales-Gómez, M.E.; Velasco-Gallegos, G.; Villar-Kuri, J. 2009: Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery International Journal of Clinical Pharmacology and Therapeutics 47(2): 89-95
Jesam, C.; Salvatierra, A.M.; Schwartz, J.L.; Fuentes, A.; Croxatto, H.B. 2014: Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial Contraception 90(2): 168-173
Senna, G.; Bilò, M.B.; Antonicelli, L.; Schiappoli, M.; Crivellaro, M.A.; Bonadonna, P.; Dama, A.R. 2004: Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients European Annals of Allergy and Clinical Immunology 36(6): 215-218
Hester, K.E.; Harper, M.J.K.; Duffy, D.M. 2010: Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception Human Reproduction 25(2): 360-367